A randomized, placebo-controlled trial of repeated IV antibiotic therapy for lyme encephalopathy prolonged Lyme disease treatment: Enough is enough

Neurology

Volumn 72, Issue 4, 2009, Pages 383-384

  Marques, A ^a   Shaw, P ^a   Schmid, C H ^a   Steere, A ^a   Kaplan, R F ^a   Hassett, A ^a   Shapiro, E ^a   Wormser, G P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; PLACEBO; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; BRAIN DISEASE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; HUMAN; LETTER; LYME DISEASE; PRIORITY JOURNAL; RANDOMIZATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; NOTE; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; TIME;

ANTI-BACTERIAL AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; LYME DISEASE; LYME NEUROBORRELIOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 67650477445     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000343855.45704.7c     Document Type: Letter

References (5)

1. BA Fallon JG Keilp KM Corbera A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy Neurology 70 2008 992 1003
2. Guidance for Industry E9 Statistical principles for clinical trials. US Department of Health and Human Services Food and Drug Administration Federal Register on September 16, 1998 (63 FR 49583) Available at: http://www.fda.gov/cder/guidance/index.htm Accessed February 7, 2008.
3. KP Burnham DR Anderson Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach 1998 Springer New York
4. J Ye On measuring and correcting the effects of data mining and model selection J Am Stat Assoc 1998 120 131
5. GP Wormser RJ Dattwyler ED Shapiro The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America Clin Infect Dis 43 2006 1089 1134